Pronounced influence of presystemic metabolism on the metabolic disposition of imrecoxib in renally impaired patients
- PMID: 31897535
- DOI: 10.1007/s00228-019-02824-9
Pronounced influence of presystemic metabolism on the metabolic disposition of imrecoxib in renally impaired patients
Comment on
-
Pharmacokinetic study of imrecoxib in patients with renal insufficiency.Eur J Clin Pharmacol. 2019 Oct;75(10):1355-1360. doi: 10.1007/s00228-019-02698-x. Epub 2019 Jun 27. Eur J Clin Pharmacol. 2019. PMID: 31243478 Clinical Trial.
Similar articles
-
Dose investigation of imrecoxib in patients with renal insufficiency based on modelling and simulation.Eur J Pharm Sci. 2020 Sep 1;152:105449. doi: 10.1016/j.ejps.2020.105449. Epub 2020 Jul 1. Eur J Pharm Sci. 2020. PMID: 32621967
-
Pharmacokinetic study of imrecoxib in patients with renal insufficiency.Eur J Clin Pharmacol. 2019 Oct;75(10):1355-1360. doi: 10.1007/s00228-019-02698-x. Epub 2019 Jun 27. Eur J Clin Pharmacol. 2019. PMID: 31243478 Clinical Trial.
-
Response by Pei et al. to letters regarding article, "Pharmacokinetic study of imrecoxib in patients with renal insufficiency".Eur J Clin Pharmacol. 2020 Mar;76(3):473-474. doi: 10.1007/s00228-019-02826-7. Epub 2020 Jan 2. Eur J Clin Pharmacol. 2020. PMID: 31897531 No abstract available.
-
Drug administration in patients with renal insufficiency. Minimising renal and extrarenal toxicity.Drug Saf. 1997 Mar;16(3):205-31. doi: 10.2165/00002018-199716030-00005. Drug Saf. 1997. PMID: 9098657 Review.
-
[Drug pharmacokinetics in renal failure: What's new?].Nephrol Ther. 2015 Jun;11(3):144-51. doi: 10.1016/j.nephro.2014.12.006. Epub 2015 Apr 7. Nephrol Ther. 2015. PMID: 25861715 Review. French.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources